Back to top

Tale of the Tape

Zacks Equity Research

Agios Pharmaceuticals (AGIO) in Focus: Stock Tumbles 8.1%
March 12, 2014


Trades from $3
Agios Pharmaceuticals, Inc. (AGIO - Analyst Report) saw a big move last session, as the company’s shares fell more than 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for AGIO as the stock is now up around 37.7% in the past one-month time frame.

This slump shouldn’t be too much of a surprise to investors, as the company has seen 2 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

AGIO currently has a Zacks Rank #4 (Sell) while its Earnings ESP is Zero.

Some better-ranked stocks in the health care sector include Covidien plc , SurModics, Inc. (SRDX - Analyst Report) and Stryker Corporation (SYK - Analyst Report) . All these stocks carry a Zacks Rank #2 (Buy). 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>